id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0130-0001,FDA,FDA-2011-N-0130,Investigational New Drug Applications and Abbreviated New Drug Applications,Rule,NFR-Notice of Final Rule,2011-03-15T04:00:00Z,2011,3,2011-03-15T04:00:00Z,,2011-03-15T18:33:35Z,2011-05946,0,0,0900006480c07efc